☆ 4.8 Article

Prolonged viral suppression with anti-HIV-1 antibody therapy

NATURE (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

Alice Cho et al.

Summary: HIV-1 infection leads to the formation of a long-lasting reservoir of latently infected CD4(+) T cells, consisting of intact and defective proviruses. This study used Q4PCR to quantify the reservoir content and found that the defective reservoir remained stable while the intact proviral reservoir decayed over time. Both the intact and defective proviral reservoirs showed dynamic changes, with an enrichment of intact proviruses in expanded CD4(+) T cell clones and a decrease in overall reservoir complexity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Immunology

Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia

Yoshiaki Nishimura et al.

Summary: The study found that combination bNAb immunotherapy initiated on day 3 post-infection maintained durable CD8(+) T cell-mediated suppression of SHIVAD8 viremia and CD4(+) T cell levels in most of the treated monkeys during nearly 6 years of observation, with CD8(+) T cell immunity being the principal correlate of virus control. Treatment interventions beginning on week 2 post-infection also conferred controller status to some monkeys, but the time to suppression of plasma viremia was significantly delayed compared to early intervention on day 3.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Immunology

Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

Rajesh T. Gandhi et al.

Summary: Intact, replication-competent proviruses are selectively lost over time during suppressive ART, while defective provirus levels remain stable. The proportion of intact proviruses within the total HIV-1 DNA reservoir decreases over time on ART. Levels of intact proviruses on ART are correlated with total HIV-1 DNA and residual plasma viremia, but not with markers of inflammation or immune activation.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA

Christian Gaebler et al.

Summary: The study compared two novel assays, IPDA and Q4PCR, for measuring intact HIV proviral DNA in samples from 39 ART-suppressed people living with HIV, showing a 19-fold difference in frequencies of intact proviral DNA. This disparity may be partially due to inefficiencies in long-distance PCR amplification and the presence of intact proviruses with defects in other parts of the genome. The head-to-head comparison provides context for interpreting the results of the assays and highlights the importance of both methods in accurately quantifying the replication-competent HIV reservoir.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Immunology

Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence

Amy S. Huang et al.

Summary: Latent intact HIV-1 proviruses persist in long-lived CD4(+) T cells and can undergo clonal expansion. Expanded clones of CD4(+) T cells in the latent reservoir seem to preferentially integrate within ZNF genes, which may contribute to maintaining HIV-1 latency.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4(+) T cells in vivo

Francesco R. Simonetti et al.

Summary: The study highlights that antigen-driven clonal selection plays a major role in HIV-1 persistence, posing a difficult challenge for eradication efforts. The research demonstrates a link between antigen responsiveness, proviral sequence, integration site, and TCR beta sequence in understanding the mechanisms behind maintaining the HIV-1 reservoir.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Medicine, General & Internal

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

L. Corey et al.

Summary: The study found that broadly neutralizing antibodies did not prevent HIV-1 acquisition more effectively than placebo, but analyses of VRC01-sensitive HIV-1 isolates indicated that prophylaxis with broadly neutralizing antibodies may be effective.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Cell Biology

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Devi SenGupta et al.

Summary: TLR7 agonist vesatolimod, when combined with ART, showed potential to delay viral rebound in HIV-1-infected controllers by reducing intact proviral DNA levels at the end of treatment. Further larger clinical studies are needed to evaluate the efficacy of vesatolimod-based combination therapies for long-term control of HIV infection.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Broadly neutralizing antibody derived CAR T cells reduce viral reservoir in individuals infected with HIV-1

Bingfeng Liu et al.

Summary: This study investigated the safety and antiviral activity of bNAb-derived CAR T cell therapy in individuals infected with HIV-1 undergoing analytical interruption of antiretroviral therapy. The therapy was found to be safe and effective, reducing viral reservoir, but rebound was due to viral escape mutations.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Immunology

Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy

Shane D. Falcinelli et al.

Summary: This study demonstrates a close relationship between the frequencies of intact proviral DNA measured by IPDA and replication-competent HIV measured by QVOA. IPDA shows promise as a high-throughput approach to estimate changes in the frequency of the replication-competent reservoir.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity

Julia Niessl et al.

NATURE MEDICINE (2020)

Add to Collection

Review Immunology

Broadly neutralizing antibodies for the treatment and prevention of HIV infection

Marina Caskey

CURRENT OPINION IN HIV AND AIDS (2020)

Add to Collection

Article Medicine, Research & Experimental

Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy

Annukka A. R. Antar et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Immunology

Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir

Pilar Mendoza et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

Mohamed Abdel-Mohsen et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

Lynn N. Bertagnolli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Medicine, Research & Experimental

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy

Michael J. Peluso et al.

JCI INSIGHT (2020)

Add to Collection

Article Medicine, Research & Experimental

Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy

Kevin B. Einkauf et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Multidisciplinary Sciences

A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

Katherine M. Bruner et al.

NATURE (2019)

Add to Collection

Article Immunology

Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir

Christian Gaebler et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Add to Collection

Article Immunology

How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?

David M. Margolis et al.

JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation

Lillian B. Cohn et al.

NATURE MEDICINE (2018)

Add to Collection

Article Immunology

Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117

Yehuda Z. Cohen et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Pilar Mendoza et al.

NATURE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

Yotam Bar-On et al.

NATURE MEDICINE (2018)

Add to Collection

Article Immunology

Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

Nina N. Hosmane et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Add to Collection

Article Immunology

Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents

David M. Margolis et al.

JOURNAL OF INFECTIOUS DISEASES (2017)

Add to Collection

Article Multidisciplinary Sciences

Early antibody therapy can induce long-lasting immunity to SHIV

Yoshiaki Nishimura et al.

NATURE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey et al.

NATURE MEDICINE (2017)

Add to Collection

Article Cell Biology

Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants

Bonnie Hiener et al.

CELL REPORTS (2017)

Add to Collection

Article Multidisciplinary Sciences

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Johannes F. Scheid et al.

NATURE (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Defective proviruses rapidly accumulate during acute HIV-1 infection

Katherine M. Bruner et al.

NATURE MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

K. J. Bar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA

Julio C. C. Lorenzi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Article Biochemistry & Molecular Biology

HIV-1 Integration Landscape during Latent and Active Infection

Lillian B. Cohn et al.

CELL (2015)

Add to Collection

Review Immunology

The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

Stylianos Bournazos et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

Ariel Halper-Stromberg et al.

CELL (2014)

Add to Collection

Review Biochemical Research Methods

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Marcella Sarzotti-Kelsoe et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Add to Collection

Article Multidisciplinary Sciences

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1

Alison L. Hill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure

Ya-Chi Ho et al.

CELL (2013)

Add to Collection

Article Multidisciplinary Sciences

Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues

Anthony P. West et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Add to Collection

Review Cell Biology

Altering cell death pathways as an approach to cure HIV infection

A. D. Badley et al.

CELL DEATH & DISEASE (2013)

Add to Collection

Article Multidisciplinary Sciences

Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses

Hugo Mouquet et al.

PLOS ONE (2011)

Add to Collection

Article Virology

HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

Toshiyuki Miura et al.

JOURNAL OF VIROLOGY (2009)

Add to Collection

Article Virology

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing

Jesus F. Salazar-Gonzalez et al.

JOURNAL OF VIROLOGY (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

JD Siliciano et al.

NATURE MEDICINE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.